NCT06019780 is a NA clinical trial of blood flow restriction trainin in Adhesive Capsulitis, sponsored by Riphah International University.

Who is sponsoring NCT06019780?

NCT06019780 is sponsored by Riphah International University.

What drugs are being tested in NCT06019780?

Interventions in NCT06019780: blood flow restriction trainin, exercise.

What condition does NCT06019780 study?

NCT06019780 studies Adhesive Capsulitis.

Is NCT06019780 still recruiting?

NCT06019780 is currently completed. Last updated 21 May 2024.

Last reviewed 2024-05-21 · How we verify

NCT06019780

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Blood Flow Restriction Training in Patients With Adhesive Capsulitis

Completed NA Last updated 21 May 2024

What this trial tests

NA trial testing blood flow restriction trainin in Adhesive Capsulitis in 36 participants. Completed in 25 February 2024.

Timeline

1 September 2023

Primary endpoint
30 January 2024

25 February 2024

Quick facts

Lead sponsor	Riphah International University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	36
Start date	1 September 2023
Primary completion	30 January 2024
Estimated completion	25 February 2024
Sites	1 location across Pakistan

Drugs / interventions tested

blood flow restriction trainin
exercise

Conditions studied

Adhesive Capsulitis — all drugs for Adhesive Capsulitis →

Sponsor

Riphah International University

Who can join

Adults 40 to 60, any sex, with Adhesive Capsulitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this research is to determine the effect of blood flow restriction training on shoulder pain, range of motion, muscle strength and shoulder. Randomized controlled trials will be done at Lady Reading Hospital Peshawar and Shahab Orthopedic General Hospital. The sample size is 36. The subjects will be divided in two groups, 18 subjects in BFR group and 18 in no BFR group. Study duration is 6 months. Sampling technique applied was non probability connivance sampling technique. Tools used in the study are SPADI shoulder score, NPRS, hand held dynamometer, sphygmomanometer and goniometer.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Adhesive Capsulitis

Currently open trials in the same condition.

NCT07486193 — Effects of Nunchaku Exercise for Improving Frozen Shoulder · NA · recruiting
NCT07493213 — USG-Guided Shoulder Injections in Frozen Shoulder · NA · recruiting
NCT07493226 — Efficacy of Chemically Distinct Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and Pain Phenotypes in Adhesive Capsulitis · NA · recruiting
NCT07495306 — Electrophysiologic Changes After Extended 360° Capsular Release · recruiting
NCT07410845 — Operative vs Non Operative Management of Adhesive Capsulitis: A Comparative Review · active not recruiting

Other Riphah International University trials

Trials by the same sponsor.

NCT07579585 — Effects of Photobiomodulation in Hemophilia Patients. · NA · recruiting
NCT07504276 — Tele-Rehabilitation vs Conventional Rehabilitation for Cognitive Improvement in Stroke Survivors. · NA · recruiting
NCT07484477 — Sedentary Behavior Modification, Cardiopulmonary Function & QOL Post Cardiac Surgery Patients. · NA · not yet recruiting
NCT07438587 — Comparative Effects of Cadence Training vs Elliptical Training in Cricketers · NA · not yet recruiting
NCT07484399 — Comparing Effects of HIIT and MICT on Functional Mobility, Muscle Strength, and Quality of Life in Diabetic Patients · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06019780 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Riphah International University
Last refreshed: 21 May 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06019780.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing